Nu Skin Reiterates Greater China Regional Sales Goal In Advance Of Meetings With Sales Leaders

 Nu Skin Reiterates Greater China Regional Sales Goal In Advance Of Meetings
                              With Sales Leaders

Date for first quarter earnings release also announced

PR Newswire

PROVO, Utah, April 19, 2013

PROVO, Utah, April 19, 2013 /PRNewswire/ --In connection with its annual
incentive trip for Greater China sales leaders,Nu Skin Enterprises (NYSE:NUS)
today reiterated itsgoal of reaching $1 billion in annual revenue in the
Greater China region by 2014.

"In 2010, when we set our $1 billion sales goal for the Greater China region,
it seemed like an aspirational target," said Truman Hunt, chief executive
officer, "However, with momentum building in the region and the positive
response we are receiving from customers in this growing market, we now
believe the goal is achievable well within the original time frame.

"Furthermore, we continue to work towards our long-term vision of achieving $5
billion in global annual revenue by 2020. We believe that our global business
will continue to perform well into the future as we continue to build on our
innovative ageLOC product platform, including our new weight management system
scheduled to be introduced later this year."

In addition to the Greater China sales trip, the company will also host its
annual Nu Skin Korea convention in Seoul next week. South Korea is one of the
company's top markets, and the convention will highlight the ageLOC Body Spa,
one of the company's most recent innovations. 

The company will release first-quarter results before the opening of the
financial market and hold a call with the investment community on May 2, 2013.
At that time, the company will provide additional information on the outlook
for the second quarter as well as the remainder of 2013. The call will take
place at 11 a.m. (EDT). The event will also be webcast on the company's
website at

About Nu Skin Enterprises
Nu Skin Enterprises, Inc. demonstrates its tradition of innovation through its
comprehensive anti-aging product portfolio, independent business opportunity
and corporate social responsibility initiatives. The company's scientific
leadership in both skin care and nutrition has established Nu Skin as a
premier anti-aging company. The company's anti-aging products feature the new
ageLOC® suite of products including the ageLOC® R^2 nutritional supplement,
ageLOC® Galvanic Spa System and ageLOC® Galvanic Body Spa™, as well as the
ageLOC® Transformation daily skin care system. A global direct selling
company, Nu Skin operates in 53 markets worldwide and is traded on the New
York Stock Exchange under the symbol "NUS." More information is available at

Please Note: This press release contains forward-looking statements within the
meaning of Section 27A of the Securities Act of 1933, as amended, and Section
21E of the Securities Exchange Act of 1934, as amended that represent the
company's current expectations and beliefs. All statements other than
statements of historical fact are "forward-looking statements" for purposes of
federal and state securities laws and include, but are not limited to,
statements of management's expectations regarding the company's performance,
initiatives, goals, strategies and new product introductions; statements of
projections regarding global and Mainland China sales targets and goals;
statements of belief; and statements of assumptions underlying any of the
foregoing. In some cases, you can identify these statements by forward-looking
words such as "believe," "expect," "project," "anticipate," "estimate,"
"intend," "plan," "targets," "likely," "will," "would," "could," "may,"
"might," the negative of these words and other similar words.

The forward-looking statements and related assumptions involve risks and
uncertainties that could cause actual results and outcomes to differ
materially from any forward-looking statements or views expressed herein.
These risks and uncertainties include, but are not limited to, the following:

  oany changes in operations or future financial results from those currently
  oany failure of current or planned initiatives or products to generate
    interest among distributors and customers and generate sponsoring and
    selling activities on a sustained basis;
  orisks related to accurately predicting, delivering or maintaining
    sufficient quantities of products to support our planned initiatives or
    launch strategies, including possible ingredient supply limitations;
  orisk of foreign currency fluctuations and the currency translation impact
    on the company's business associated with these fluctuations;
  oregulatory risks associated with the company's products, which could
    require the company to modify its claims or inhibit the company's ability
    to import or continue selling a product in a market if it is determined to
    be a medical device or if it is unable to register the product in a timely
    manner under applicable regulatory requirements;
  oany inability to secure necessary governmental approvals or licenses to
    effect any future changes or expansion;
  ocontinued regulatory scrutiny and investigations in Mainland China, which
    have from time to time in the past, and could in the future, negatively
    impact the company's business, including the interruption of sales
    activities in stores, loss of licenses, and the imposition of fines;
  oadverse publicity related to the company's business, products, industry or
    any legal actions or complaints by distributors or others; and
  ocontinued competitive pressures in the company's markets.

The company's financial performance and the forward-looking statements
contained herein are further qualified by a detailed discussion of associated
risks set forth in the documents filed by the company with the Securities and
Exchange Commission. The forward-looking statements set forth the company's
beliefs as of the date that such information was first provided and the
company assumes no duty to update the forward-looking statements contained in
this release to reflect any change except as required by law.

SOURCE Nu Skin Enterprises, Inc.

Contact: Investors — Scott Pond, +1-801-345-2657,; Media —
Kara Schneck, +1-801-345-2116,
Press spacebar to pause and continue. Press esc to stop.